NervGen Pharma Corp. (TSXV:NGEN)
Canada
· Delayed Price · Currency is CAD 5.61
+0.15 (2.75%)
Mar 9, 2026, 3:59 PM EST
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 434.88 million as of March 9, 2026. Its market cap has increased by 112.05% in one year.
Market Cap
434.88M
Enterprise Value
423.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.61
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 434.88M, an increase of 768.53%. That is a compound annual growth rate of 36.30%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 334.16M |
| Eupraxia Pharmaceuticals | 655.97M |
| Bright Minds Biosciences | 1.01B |
| Helix BioPharma | 158.87M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 68.40M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 56.27M |